Seventy per cent of the people who received a booster dose of the Covid vaccine did not contract the disease during the third wave, according to a new study that covered around 6,000 people in India. The study led by Dr Rajeev Jayadevan, co-chairman of the Indian Medical Association’s national task force on coronavirus, said … Read more
A day before the Covid-19 booster shoot drive is rolled out, both major vaccine manufacturers went on to announce a massive price cut on their vaccines. The Covid-19 vaccines Covishied which is manufactured by the Serum Institute of India and Covaxin from Bharat Biotech earlier used to cost Rs 600 and Rs 1200 respectively, but … Read more
Serum Institute of India has cut the price of the Covishield precaution (booster) dose at private hospitals by more than half, a day before booster shots become available to all Indian adults, CEO Adar Poonawalla announced. The price of a single dose has been slashed to Rs 225 from Rs 600 earlier. The decision was … Read more
A recent ICMR study has shown that breakthrough cases after full vaccination with Covaxin have shown a significant increase in the immune response against coronavirus’ variants of concern — Beta, Delta and Omicron. Individuals who recovered from Covid also showed significant immunity boost post-vaccination with Covaxin but lower than the breakthrough cases.However, those who had … Read more
In the light of the World Health Organisation (WHO)’s move to suspend supply of Covaxin produced by Hyderabad- headquartered Bharat Biotech, through UN procurement agencies, those in the Indian vaccine industry feel the focus will now increasingly be on the Indian drug regulator – the office of the Drugs Controller General of India (DCGI) and … Read more
Scientists at the Indian Council of Medical Research-National Institute of Virology (ICMR-NIV) have undertaken a nationwide bat surveillance to check for zoonotic diseases. The scientists are taking bat samples and testing for the Nipah virus. Senior ICMR-NIV scientist Dr Pragya Yadav told The Indian Express that the survey would help identify Nipah virus hotspots. Based on this, … Read more
India is yet to approve the use of intranasal vaccine against COVID-19, BBV154 developed by the Hyderabad based company. The AIIMS will start the booster dose trial of Bharat Biotech’s intranasal COVID-19 vaccine from Friday. The booster dose will be given to those who have received both the doses of either Covaxin or Covishield at … Read more
Covaxin (BBVI52), which has been developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), is an investigational vaccine candidate product in the US. Bharat Biotech on Saturday said its Covaxin will be evaluated as a COVID-19 vaccine candidate in the US. In a statement, Ocugen Inc, Bharat Biotech’s partner in … Read more
Large-scale vaccination helped India counter the third wave, as attested by top institutes across the world and ICMR, the minister added. Union Health Minister Mansukh Mandaviya said on Saturday that the central government will roll out COVID-19 vaccination for children in the age group of 5 to 15 years as soon as it receives recommendation … Read more
As per the Registrar General of India (RGI), the estimated population of beneficiaries in the age group of 15-18 years is 7.4 crore for 2021-22. Over one crore adolescents in the 15-18 years age group nationwide are now fully vaccinated against the novel coronavirus infection, Union Health Minister Mansukh Mandaviya said on Wednesday. Over 5.04 … Read more